Ernexa Therapeutics Inc. Deferred Federal Income Tax Expense (Benefit)
Ernexa Therapeutics Inc. (ERNA) reported Deferred Federal Income Tax Expense (Benefit) of $19.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-13
- Ernexa Therapeutics Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $19.00K.
- Ernexa Therapeutics Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$2.15M.
- Ernexa Therapeutics Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$6.85M.
- Ernexa Therapeutics Inc. deferred federal income tax expense (benefit) for fiscal 2021 was -$5.84M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $19.00K 10-K · filed 2026-03-13 | |
| 2023-12-31 | -$2.15M 10-K · filed 2024-03-14 | |
| 2022-12-31 | -$6.85M 10-K · filed 2024-03-14 | |
| 2021-12-31 | -$5.84M 10-K · filed 2023-03-20 | -$5.84M 10-K · filed 2022-04-15 |
| 2020-12-31 | $0.00 10-K/A · filed 2022-07-01 | |
| 2014-12-31 | $0.00 10-K · filed 2015-03-27 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-27 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |